May 5, 2020 / 6:40 AM / 25 days ago

BRIEF-Medivir Q1 EBITDA Loss Narrows To SEK 20.7 Million

May 5 (Reuters) - Medivir AB:

* INTERIM REPORT JANUARY - MARCH 2020

* Q1 NET TURNOVER AMOUNTED TO SEK 7.3 (2.0) MILLION

* Q1 LOSS BEFORE INTEREST, TAX, DEPRECIATION AND AMORTIZATION (EBITDA) AMOUNTED TO SEK -20.7 (-54.2) MILLION

* IN OUR INDUSTRY, COVID-19 PANDEMIC HAS IMPACTED RECRUITMENT TO CLINICAL TRIALS

* RECRUITMENT FOR ONGOING PHASE IB STUDY WITH MIV-818 IS LIKELY TO BE SLOWER THAN EXPECTED

* TOPLINE DATA FROM PHASE IB STUDY IS NOT EXPECTED UNTIL Q1 OF 2021 Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below